Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

US Patent 11406646 · Granted Aug 9, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sustained release drug delivery systems and related methods2025
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2025
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2025
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2025
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2025
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2025
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2025
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2025
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceut2025
Sustained release drug delivery systems with reduced impurities and related meth2023
Uses of oxygenated cholesterol sulfates (OCS)2023
Uses of oxygenated cholesterol sulfates (OCS)2023